Buprenorphine Microinduction: Logistical Barriers and the Need for Convergent Evidence
De Aquino JP, Parida S, Sofuoglu M. Buprenorphine Microinduction: Logistical Barriers and the Need for Convergent Evidence. Clinical Drug Investigation 2021, 41: 665-665. PMID: 34106434, DOI: 10.1007/s40261-021-01049-y.Peer-Reviewed Original ResearchBlisterBuprenorphineHumansOpioid-Related DisordersPatient-Centered CarePractice Patterns, Physicians'